SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 253 filers reported holding SAGE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.89 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $229,000 | -23.4% | 1,633 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $299,000 | +15.0% | 1,633 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $260,000 | +12.6% | 1,633 | 0.0% | 0.00% | +100.0% |
| Q3 2018 | $231,000 | -9.8% | 1,633 | 0.0% | 0.00% | -50.0% |
| Q2 2018 | $256,000 | +23.1% | 1,633 | +26.4% | 0.00% | +100.0% |
| Q1 2018 | $208,000 | -2.3% | 1,292 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $213,000 | – | 1,292 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 312,000 | $29,886,000 | 5.11% |
| DAFNA Capital Management LLC | 104,306 | $9,991,000 | 4.97% |
| Palo Alto Investors LP | 850,977 | $81,515,000 | 4.34% |
| BB BIOTECH AG | 1,375,229 | $131,733,000 | 4.22% |
| Eventide Asset Management | 936,000 | $89,659,000 | 3.97% |
| TRV GP II, LLC | 37,362 | $3,579,000 | 3.56% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 146,179 | $14,002,000 | 2.11% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 111,908 | $10,720,000 | 2.06% |
| OAK RIDGE INVESTMENTS LLC | 231,483 | $22,174,000 | 1.60% |
| Rhenman & Partners Asset Management AB | 137,339 | $13,156,000 | 1.50% |